BLI Banque de Luxembourg Investments Decreases Stock Position in The Clorox Company $CLX

BLI Banque de Luxembourg Investments lowered its stake in The Clorox Company (NYSE:CLX) by 5.6% during the 4th quarter, Holdings Channel reports. The firm owned 169,720 shares of the company’s stock after selling 10,000 shares during the quarter. BLI Banque de Luxembourg Investments’ holdings in Clorox were worth $17,113,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Center for Financial Planning Inc. purchased a new stake in Clorox in the 3rd quarter worth $25,000. Vermillion & White Wealth Management Group LLC purchased a new stake in Clorox in the 3rd quarter worth $25,000. Darwin Wealth Management LLC purchased a new stake in Clorox in the 2nd quarter worth $29,000. Vision Financial Markets LLC lifted its stake in Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares in the last quarter. Finally, Ameriflex Group Inc. lifted its stake in Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock worth $36,000 after purchasing an additional 273 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Activity

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction on Tuesday, May 5th. The stock was acquired at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the transaction, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.63% of the stock is owned by company insiders.

Clorox Stock Up 1.0%

Shares of NYSE CLX opened at $95.11 on Tuesday. The firm’s 50-day moving average price is $96.81 and its 200-day moving average price is $105.31. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The stock has a market capitalization of $11.50 billion, a price-to-earnings ratio of 15.44, a P/E/G ratio of 0.49 and a beta of 0.56. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $132.03.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the prior year, the company earned $1.45 EPS. The business’s revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts anticipate that The Clorox Company will post 5.61 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have commented on the stock. Royal Bank Of Canada decreased their price target on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. Evercore reiterated an “underperform” rating and issued a $110.00 price target on shares of Clorox in a research note on Friday, May 1st. Jefferies Financial Group decreased their price target on shares of Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Wells Fargo & Company decreased their target price on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research report on Monday, May 18th. Finally, Rothschild & Co Redburn set a $117.00 target price on shares of Clorox in a research report on Friday, February 13th. One analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Reduce” and an average price target of $103.40.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.